Madrigal: Rezdiffra Shift To F4c MASH Cirrhosis Continues With 2-Year Data

Rezdiffra FDA approval fuels sales; expansion to F4 MASH cirrhosis with 2027 trial data. Read more about MDGL stock here.
IEEE

Approximate Dynamic Programming for Control of Wave Energy Converters With Implementation ...

Abstract: It is recognized that the application of constrained optimal control for wave energy converters (WECs), represented by model predictive control (MPC), is hindered by its computation burden ...